Are SGLT2 Inhibitors' Cardiorenal Benefits a Nervous System Effect?

<![CDATA[]]>(MedPage Today) — How SGLT2 inhibition may confer cardiorenal protection may be explained at least in part by dampening the sympathetic nervous system (SNS), preclinical research suggested.
Chemical denervation in non-diabetic, hypertensive mice…

Source link

Related posts

Treating Hypertension in Children With n-of-1 Trials


Expectant mothers can prevent fetal brain problems caused by the flu, study shows


Higher BMI, Higher Risk of Slipped Capital Femoral Epiphysis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy